Breslin provides strategic advice and support for private equity and secondary transactions as well as for corporate development and corporate finance. Breslin is also a preeminent international corporate development and financial advisor to firms within the Life Sciences- and IT industry. The company's purpose is to create strategies that permit its client's transactions achieve their full commercial potential.
Our clients include Private Equity, Venture Capital, Global Financial Service Providers as well as Companys in Pharmaceutical, Biotech, Medical Device, Diagnostic and IT areas. To date, Breslin has raised funds in excess of €300m and executed financial transactions totaling €1.0 billion. Breslin has a distinguished team of international scientific, financial and technological experts that are most valued for their advice and execution. Breslin has a global reach with offices in Zurich, Munich, Frankfurt and London.